Replimune Group Inc - ESG Rating & Company Profile powered by AI
This ESG score covers 17 United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life on Land'. Browse to the bottom of this webpage for potential risks for Replimune Group Inc based on sector, geography and size. The ESG assessment for Replimune Group Inc indicates its transparency towards the United Nations Sustainable Development Goals.
Replimune Group Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Replimune Group Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Replimune Group Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Replimune Group Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Replimune Group Inc report the average age of the workforce?
Sign up for free to unlockDoes Replimune Group Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Replimune Group Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Replimune Group Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Replimune Group Inc offer flexible work?
Sign up for free to unlockDoes Replimune Group Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Replimune Group Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Replimune Group Inc conduct supply chain audits?
Sign up for free to unlockDoes Replimune Group Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Replimune Group Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Replimune Group Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Replimune Group Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Replimune Group Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Replimune Group Inc disclose water use targets?
Sign up for free to unlockDoes Replimune Group Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Replimune Group Inc have a product recall in the last two years?
Sign up for free to unlockDoes Replimune Group Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Replimune Group Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Replimune Group Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Replimune Group Inc disclose parental leave metrics?
Sign up for free to unlockDoes Replimune Group Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Replimune Group Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Replimune Group Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Replimune Group Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Replimune Group Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Replimune Group Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Replimune Group Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Replimune Group Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Replimune Group Inc disclose its waste policy?
Sign up for free to unlockDoes Replimune Group Inc report according to TCFD requirements?
Sign up for free to unlockDoes Replimune Group Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Replimune Group Inc disclose energy use targets?
Sign up for free to unlockDoes Replimune Group Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Replimune Group Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Replimune Group Inc
These potential risks are based on the size, segment and geographies of the company.
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.